Network meta-analysis and its role in evidence-based decision-making

Watch Now

Sponsored by:

ICON
Date:
July 8, 2025
Time (PT):
10:00 AM
No items found.

Discover how NMA enhances comparative effectiveness research, informs healthcare policies, and drives optimized patient outcomes in an evolving treatment landscape.

In an increasingly complex healthcare landscape, network meta-analysis (NMA) has become a powerful tool for comparing multiple treatments, even when direct head-to-head trials are lacking. By synthesizing direct and indirect evidence, NMA provides a robust framework for assessing treatment effectiveness, safety, and cost-effectiveness, making it an essential component of evidence-based decision-making.

Payers, health technology assessment (HTA) agencies, and pharmaceutical companies rely on NMA to rank interventions, support reimbursement decisions, and strengthen regulatory submissions.

This session provides an in-depth exploration of NMA methodologies, practical applications, and real-world impact. Attendees engage with case studies and gain hands-on experience using R packages such as netmeta and multinma, equipping them with practical skills to conduct and interpret NMAs effectively.

Presenters

Daniel Gallardo

ICON
Senior Consultant

Daniel Gallardo joined ICON’s Health Economics & Epidemiology team in 2024 as a Senior Consultant. He brings deep expertise in Health Technology Assessment (HTA) and meta-analytic methods, with a strong specialization in Bayesian statistical modelling. His current work focuses on advanced evidence synthesis—including network meta-analysis (NMA), dose-response, and multilevel models—supporting decision-making in healthcare. Proficient in both Bayesian and frequentist approaches, Daniel designs and implements rigorous statistical analysis plans, primarily using R. He has extensive experience with packages such as multinma, MBNMAdose, MBNMAtime, and BUGSnet, ensuring robust and interpretable results for complex HTA submissions.

Read More

Nathan Green

University College London (Department of Statistical Science)
Senior Research Fellow

Nathan Green has a number of years experience working on a wide range of projects across government and academia in defense and health, and currently works in the Department of Statistical Science at UCL.

Read More

Ankit Pahwa

ICON (Real World Evidence Strategy and Analytics)
Lead Epidemiologist

Ankit Pahwa has 14 years of experience in statistical modelling, analytics, and programming. At ICON, he is involved in chart review studies, cross-sectional survey studies, and indirect treatment comparison using external control arm.

Read More

Sponsor

ICON

Our mission has been to help our clients to accelerate the development of drugs and devices that save lives and improve quality of life.

Related Content

Related Content